ULBI.NASDAQUltralife CORP

10-Q: Ultralife Corporation Reports 21% Revenue Increase in Q1 2025 Driven by Electrochem Acquisition and Government/Defense Sales

Sentiment:

Quarterly Report


Ultralife Corporation's Q1 2025 revenue increased by 21% year-over-year, primarily due to the acquisition of Electrochem and growth in government/defense sales, though profitability was impacted by sales mix and increased operating expenses.

Worse than expectedNet income attributable to Ultralife Corporation was $1.865 million, or $0.11 per share, compared to $2.891 million, or $0.18 per share, in Q1 2024.Gross margin declined from 27.4% to 25.1% due to unfavorable sales mix.Operating expenses increased by 26.2%, including costs related to Electrochem and increased R&D spending.

Summary

  • Ultralife Corporation's Q1 2025 revenue reached $50.746 million, a 21% increase compared to $41.927 million in Q1 2024.
  • The revenue growth was driven by the inclusion of Electrochem and an increase in government/defense sales.
  • However, commercial sales decreased by 8.7% when excluding Electrochem's sales.
  • Gross profit was $12.745 million, representing 25.1% of revenue, down from 27.4% in the same period last year, due to sales product mix.
  • Operating expenses increased to $9.346 million, reflecting the inclusion of Electrochem, higher new product development costs, and one-time expenses.
  • Operating income decreased to $3.399 million, or 6.7% of revenues, compared to $4.063 million, or 9.7% of revenues, in the prior year.
  • Net income attributable to Ultralife Corporation was $1.865 million, or $0.11 per share, compared to $2.891 million, or $0.18 per share, in Q1 2024.
  • Adjusted EBITDA was $5.448 million, or 10.7% of revenues, compared to $5.243 million, or 12.5% of revenues, in the first quarter of 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue increased due to the acquisition, profitability metrics declined, and a material weakness in internal control was identified. Management expresses confidence in future growth, but the current results present mixed signals.

Positives

  • The acquisition of Electrochem contributed to revenue growth and expanded Ultralife's product portfolio.
  • Government/defense sales increased, indicating strong demand in this sector.
  • The company is investing in new product development to pursue growth opportunities.
  • Ultralife is actively seeking to hire additional accounting personnel to address a material weakness in internal control over financial reporting.
  • The company is in full compliance with its debt covenants under the Credit Facilities.

Negatives

  • Commercial sales decreased when excluding Electrochem's sales.
  • Gross margin declined due to unfavorable sales mix.
  • Operating expenses increased significantly, impacting profitability.
  • Net income and earnings per share decreased compared to the prior year.
  • The company has identified a material weakness in its internal control over financial reporting.

Risks

  • Changes in economic conditions, including inflation, tariffs, and supply chain disruptions, could adversely affect the business.
  • Reliance on key customers for a significant portion of revenues poses a risk.
  • Reductions or delays in U.S. and foreign military spending could impact sales.
  • Potential disruptions in the supply of raw materials and components or material increases in their costs could affect profitability.
  • Breaches in information systems security and other disruptions in information technology systems could harm the business.
  • The company's ability to recruit and retain top management and key personnel is crucial.
  • Fluctuations in the price of oil could impact the demand for downhole drilling products.
  • Safety risks, including the risk of fire inherent in the manufacture, use, and transportation of Lithium batteries, exist.
  • Variability in quarterly and annual results and the price of the company's common stock is a risk.
  • Rising interest rates could increase the cost of variable borrowings.
  • The company's entrance into new end-markets could lead to additional financial exposure.
  • Negative publicity concerning Lithium-ion batteries could impact demand.
  • The company is exposed to foreign currency fluctuations.
  • The company's ability to utilize its net operating loss carryforwards is uncertain.
  • The company faces the risk that it is unable to protect its proprietary and intellectual property.
  • The company must comply with government regulations, including the use of conflict minerals.
  • The company is exposed to possible violations of the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, or other anti-corruption laws.
  • The company faces known and unknown environmental matters.
  • The company is subject to possible audits of its contracts by the U.S. and foreign governments and their respective defense agencies.

Future Outlook

The company is confident in its ability to deliver and sustain profitable growth, generate incremental cash flow to reduce acquisition-related debt, and continue to invest in strategic product development.

Management Comments

  • The company's strong backlog replenishment this quarter, combined with a growing pipeline of innovative products targeting high-growth markets, positions it to scale efficiently and capitalize on market demand.
  • With enhanced sales and marketing leadership in place, the company is accelerating organic growth and maximizing the value of its global brand and resources.

Industry Context

The company operates in the power solutions and communications systems industries, serving government, defense, and commercial sectors globally. The acquisition of Electrochem expands Ultralife's presence in the battery technology market, particularly in primary lithium metal and ultracapacitor cells and battery packs. The company faces competition from other battery manufacturers and communications systems providers, and is subject to industry-specific risks such as safety concerns related to lithium batteries and regulations for the shipment of products.

Comparison to Industry Standards

  • It is difficult to provide a precise comparison to industry standards without more specific information on Ultralife's direct competitors and the specific segments in which they operate.
  • However, generally, a gross margin of 25.1% is within the typical range for manufacturing companies, but lower than software or service-based businesses.
  • Companies like Saft Groupe S.A. and EaglePicher Technologies, which also operate in the specialized battery market, could be considered peers, but their financial results may not be directly comparable due to differences in product mix, geographic focus, and accounting practices.
  • Similarly, in the communications systems segment, companies like L3Harris Technologies and General Dynamics may offer comparable products and services, but their overall financial performance is influenced by a broader range of activities.

Stakeholder Impact

  • Shareholders may be concerned about the decline in profitability and the identified material weakness.
  • Employees may be affected by the ongoing efforts to remediate the material weakness and the hiring of additional personnel.
  • Customers may benefit from the expanded product portfolio resulting from the Electrochem acquisition.
  • Suppliers may see increased demand due to the company's growth initiatives.
  • Creditors will be monitoring the company's compliance with debt covenants.

Next Steps

  • The company intends to continue investing in strategic product development.
  • Management will continue to take steps to remediate the identified material weakness in internal control over financial reporting, including hiring additional accounting personnel.
  • The company will monitor and manage its debt covenants under the Credit Facilities.

Key Dates

DateDescription
2021-12-13Date related to Keybank and the Term Loan Facility
2022-12-31Date related to the Amended Credit Agreement Member
2023-06-30Date related to the Amended Credit Agreement Member
2024-09-27Date of the stock purchase agreement with Greatbatch Ltd. for the acquisition of Electrochem Solutions, Inc.
2024-10-31Date of the completion of the acquisition of Electrochem Solutions, Inc.
2025-03-31End of the quarterly period covered by the report.
2025-05-08Date as of which the registrant had 16,632,965 shares of common stock outstanding.
2025-05-12Date of report filing.
2029-10-31Date when all amounts of unpaid principal and accrued and unpaid interest remaining due under the Term Loan are scheduled to be paid in full.

Keywords

Ultralife, Electrochem, Battery & Energy Products, Communications Systems, Revenue, Gross Margin, Operating Income, Net Income, Adjusted EBITDA, Government/Defense, Financial Results, Acquisition, Lithium Batteries, Internal Control, Material Weakness

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.